KYNTRA BIO, INC. (KYNB) Operating cash flow 2016–2025
KYNTRA BIO, INC. (KYNB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2016: $7.1M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +96.5% |
| FY2024 | -$138.0M | +56.2% |
| FY2023 | -$315.0M | -115.9% |
| FY2022 | -$145.9M | -77.5% |
| FY2021 | -$82.2M | -200.8% |
| FY2020 | $81.6M | +203.7% |
| FY2019 | -$78.7M | -3.4% |
| FY2018 | -$76.1M | -14.5% |
| FY2017 | -$66.5M | -1035.7% |
| FY2016 | $7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Gross marginKYNB Operating incomeKYNB Operating marginKYNB Free cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →